As innovation becomes an increasingly central focus in merger control—particularly in fast-evolving industries—competition authorities are grappling with how best to assess the impact of mergers on innovation. Unlike unilateral price effects, this area lacks a well-established framework of legal and economic tools, and there is limited consensus on the most effective types of empirical data for such assessments.
In this webinar, CRA’s Yajing Jiang, and Noah Pinegar, Partner at Kirkland & Ellis, will explore how innovation is being assessed in recent merger review cases. The session will cover key topics and highlight the types of potentially useful data relevant to each:
- Defining innovation markets
- Evaluating head-to-head innovation competition
- Theories of harm related to innovation
- Potential rebuttal evidence
- Considerations for remedies
Drawing on recent enforcement actions and developments in economic literature, this presentation will offer valuable insights into the evolving landscape of innovation-focused merger analysis.
For more information on this event, click here.
